Nutricia's innovations rely on breakthrough research in nutrition and disease management, with evidence-backed products delivering clear health benefits to patients.
Nutricia’s innovations in Advanced Medical Nutrition are developed by our renowned Centre for Specialised Nutrition in Wageningen, The Netherlands. We also have a dedicated research unit in Liverpool, UK which develops highly specialised products for special needs patients in metabolics and infant allergy. In addition, there are 2 research satellites, one in the US and one in Singapore.
As part of Danone’s R&D division for food research, our research organisation is science-driven and consumer-led, with teams specialising in Baby Nutrition and Medical Nutrition. These teams develop formulations that provide optimal growth and development or proven health benefits to vulnerable consumers – infants, toddlers, the elderly and those who are sick.
We enjoy support from a strong worldwide network of numerous partners, including research institutes, universities, (academic) hospitals and industrial suppliers. In this way, innovation through quality, exclusivity and momentum is guaranteed. We continuously seek to strengthen this network.
We see enormous potential in disease targeted nutrition; focusing on improving clinical outcomes by helping to delay the progression of disease in specific areas such as Diabetes, COPD, Oncology and Alzheimer’s disease.